Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia

•Plasma epinephrine is decreased in priming models of fibromyalgia-like pain.•Clenbuterol attenuates hyperalgesia in an acid saline-induced fibromyalgia-like pain model.•Clenbuterol mitigates muscle atrophy in fibromyalgia priming model. Fibromyalgia (FM) is characterized by chronic widespread muscu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Physiology & behavior 2024-07, Vol.281, p.114575-114575, Article 114575
Hauptverfasser: da Silva, Raquel Prado, Costa, Daniely Messias, da Cruz-Filho, João, Santos, Tatiane de Oliveira, dos Anjos-Santos, Hevely Catharine, Vasconcelos, Alan Bruno Silva, Heck, Lilian Carmo, Kettelhut, Ísis do Carmo, Navegantes, Luiz Carlos, dos Santos, José Ronaldo, de Souza, Patrícia Rodrigues Marques, Badauê-Passos Jr, Daniel, Mecawi, André Souza, DeSantana, Josimari Melo, Lustrino, Danilo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 114575
container_issue
container_start_page 114575
container_title Physiology & behavior
container_volume 281
creator da Silva, Raquel Prado
Costa, Daniely Messias
da Cruz-Filho, João
Santos, Tatiane de Oliveira
dos Anjos-Santos, Hevely Catharine
Vasconcelos, Alan Bruno Silva
Heck, Lilian Carmo
Kettelhut, Ísis do Carmo
Navegantes, Luiz Carlos
dos Santos, José Ronaldo
de Souza, Patrícia Rodrigues Marques
Badauê-Passos Jr, Daniel
Mecawi, André Souza
DeSantana, Josimari Melo
Lustrino, Danilo
description •Plasma epinephrine is decreased in priming models of fibromyalgia-like pain.•Clenbuterol attenuates hyperalgesia in an acid saline-induced fibromyalgia-like pain model.•Clenbuterol mitigates muscle atrophy in fibromyalgia priming model. Fibromyalgia (FM) is characterized by chronic widespread musculoskeletal pain accompanied by fatigue and muscle atrophy. Although its etiology is not known, studies have shown that FM patients exhibit altered function of the sympathetic nervous system (SNS), which regulates nociception and muscle plasticity. Nevertheless, the precise SNS-mediated mechanisms governing hyperalgesia and skeletal muscle atrophy in FM remain unclear. Thus, we employed two distinct FM-like pain models, involving intramuscular injections of acidic saline (pH 4.0) or carrageenan in prepubertal female rats, and evaluated the catecholamine content, adrenergic signaling and overall muscle proteolysis. Subsequently, we assessed the contribution of the SNS to the development of hyperalgesia and muscle atrophy in acidic saline-injected rats treated with clenbuterol (a selective β2-adrenergic receptor agonist) and in animals maintained under baseline conditions and subjected to epinephrine depletion through adrenodemedullation (ADM). Seven days after inducing an FM-like model with acidic saline or carrageenan, we observed widespread mechanical hyperalgesia along with loss of strength and/or muscle mass. These changes were associated with reduced catecholamine content, suggesting a common underlying mechanism. Notably, treatment with a β2-agonist alleviated hyperalgesia and prevented muscle atrophy in acidic saline-induced FM-like pain, while epinephrine depletion induced mechanical hyperalgesia and increased muscle proteolysis in animals under baseline conditions. Together, the results suggest that reduced sympathetic activity is involved in the development of pain and muscle atrophy in the murine model of FM analyzed.
doi_str_mv 10.1016/j.physbeh.2024.114575
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3050172768</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0031938424001203</els_id><sourcerecordid>3050172768</sourcerecordid><originalsourceid>FETCH-LOGICAL-c313t-f51e9de8b39f3d18366e486ed0ab8773ba49a13576405d2a678592136824d44e3</originalsourceid><addsrcrecordid>eNqFkE2v1CAUhonReMerP0HD0k1HKFDoypib60dyExOjiTtC4dRhUkoFOqY7f7pMZnQrG5I3z8s5PAi9pGRPCe3eHPfLYcsDHPYtafmeUi6keIR2VEnWCCK_P0Y7Qhhteqb4DXqW85HUwzh7im6Y6vq25jv0-wu41YLDeQuLKQco3mJjiz_5smGfsck5Wm9KRX75csAVwQ5OMMUlwFxwHPFi_IzN7HBYs50Am5JiXQ6fUzxCMDVLpuAQHUznwuiHFMNmph_ePEdPRjNleHG9b9G39_df7z42D58_fLp799BYRllpRkGhd6AG1o_MUcW6DrjqwBEzKCnZYHhvKBOy40S41nRSib6lrFMtd5wDu0WvL-8uKf5cIRcdfLYwTWaGuGbNiCBUtrJTFRUX1KaYc4JRL8kHkzZNiT7L10d9la_P8vVFfu29uo5YhwDuX-uv7Qq8vQBQP3rykHS2Huaq3yewRbvo_zPiD5qWmbI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3050172768</pqid></control><display><type>article</type><title>Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>da Silva, Raquel Prado ; Costa, Daniely Messias ; da Cruz-Filho, João ; Santos, Tatiane de Oliveira ; dos Anjos-Santos, Hevely Catharine ; Vasconcelos, Alan Bruno Silva ; Heck, Lilian Carmo ; Kettelhut, Ísis do Carmo ; Navegantes, Luiz Carlos ; dos Santos, José Ronaldo ; de Souza, Patrícia Rodrigues Marques ; Badauê-Passos Jr, Daniel ; Mecawi, André Souza ; DeSantana, Josimari Melo ; Lustrino, Danilo</creator><creatorcontrib>da Silva, Raquel Prado ; Costa, Daniely Messias ; da Cruz-Filho, João ; Santos, Tatiane de Oliveira ; dos Anjos-Santos, Hevely Catharine ; Vasconcelos, Alan Bruno Silva ; Heck, Lilian Carmo ; Kettelhut, Ísis do Carmo ; Navegantes, Luiz Carlos ; dos Santos, José Ronaldo ; de Souza, Patrícia Rodrigues Marques ; Badauê-Passos Jr, Daniel ; Mecawi, André Souza ; DeSantana, Josimari Melo ; Lustrino, Danilo</creatorcontrib><description>•Plasma epinephrine is decreased in priming models of fibromyalgia-like pain.•Clenbuterol attenuates hyperalgesia in an acid saline-induced fibromyalgia-like pain model.•Clenbuterol mitigates muscle atrophy in fibromyalgia priming model. Fibromyalgia (FM) is characterized by chronic widespread musculoskeletal pain accompanied by fatigue and muscle atrophy. Although its etiology is not known, studies have shown that FM patients exhibit altered function of the sympathetic nervous system (SNS), which regulates nociception and muscle plasticity. Nevertheless, the precise SNS-mediated mechanisms governing hyperalgesia and skeletal muscle atrophy in FM remain unclear. Thus, we employed two distinct FM-like pain models, involving intramuscular injections of acidic saline (pH 4.0) or carrageenan in prepubertal female rats, and evaluated the catecholamine content, adrenergic signaling and overall muscle proteolysis. Subsequently, we assessed the contribution of the SNS to the development of hyperalgesia and muscle atrophy in acidic saline-injected rats treated with clenbuterol (a selective β2-adrenergic receptor agonist) and in animals maintained under baseline conditions and subjected to epinephrine depletion through adrenodemedullation (ADM). Seven days after inducing an FM-like model with acidic saline or carrageenan, we observed widespread mechanical hyperalgesia along with loss of strength and/or muscle mass. These changes were associated with reduced catecholamine content, suggesting a common underlying mechanism. Notably, treatment with a β2-agonist alleviated hyperalgesia and prevented muscle atrophy in acidic saline-induced FM-like pain, while epinephrine depletion induced mechanical hyperalgesia and increased muscle proteolysis in animals under baseline conditions. Together, the results suggest that reduced sympathetic activity is involved in the development of pain and muscle atrophy in the murine model of FM analyzed.</description><identifier>ISSN: 0031-9384</identifier><identifier>EISSN: 1873-507X</identifier><identifier>DOI: 10.1016/j.physbeh.2024.114575</identifier><identifier>PMID: 38692384</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adrenergic beta-Agonists - pharmacology ; Animals ; Carrageenan - toxicity ; Catecholamines - metabolism ; Clenbuterol - pharmacology ; Disease Models, Animal ; Epinephrine ; Female ; Fibromyalgia ; Fibromyalgia - pathology ; Fibromyalgia - physiopathology ; Hyperalgesia ; Hyperalgesia - pathology ; Hyperalgesia - physiopathology ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - pathology ; Muscle, Skeletal - physiopathology ; Muscular Atrophy - pathology ; Muscular Atrophy - physiopathology ; Pain - pathology ; Pain - physiopathology ; Proteolysis ; Rats ; Rats, Sprague-Dawley ; Skeletal muscle ; Sympathetic nervous system ; Sympathetic Nervous System - drug effects ; Sympathetic Nervous System - pathology ; Sympathetic Nervous System - physiopathology</subject><ispartof>Physiology &amp; behavior, 2024-07, Vol.281, p.114575-114575, Article 114575</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c313t-f51e9de8b39f3d18366e486ed0ab8773ba49a13576405d2a678592136824d44e3</cites><orcidid>0000-0001-7118-743X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0031938424001203$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38692384$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>da Silva, Raquel Prado</creatorcontrib><creatorcontrib>Costa, Daniely Messias</creatorcontrib><creatorcontrib>da Cruz-Filho, João</creatorcontrib><creatorcontrib>Santos, Tatiane de Oliveira</creatorcontrib><creatorcontrib>dos Anjos-Santos, Hevely Catharine</creatorcontrib><creatorcontrib>Vasconcelos, Alan Bruno Silva</creatorcontrib><creatorcontrib>Heck, Lilian Carmo</creatorcontrib><creatorcontrib>Kettelhut, Ísis do Carmo</creatorcontrib><creatorcontrib>Navegantes, Luiz Carlos</creatorcontrib><creatorcontrib>dos Santos, José Ronaldo</creatorcontrib><creatorcontrib>de Souza, Patrícia Rodrigues Marques</creatorcontrib><creatorcontrib>Badauê-Passos Jr, Daniel</creatorcontrib><creatorcontrib>Mecawi, André Souza</creatorcontrib><creatorcontrib>DeSantana, Josimari Melo</creatorcontrib><creatorcontrib>Lustrino, Danilo</creatorcontrib><title>Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia</title><title>Physiology &amp; behavior</title><addtitle>Physiol Behav</addtitle><description>•Plasma epinephrine is decreased in priming models of fibromyalgia-like pain.•Clenbuterol attenuates hyperalgesia in an acid saline-induced fibromyalgia-like pain model.•Clenbuterol mitigates muscle atrophy in fibromyalgia priming model. Fibromyalgia (FM) is characterized by chronic widespread musculoskeletal pain accompanied by fatigue and muscle atrophy. Although its etiology is not known, studies have shown that FM patients exhibit altered function of the sympathetic nervous system (SNS), which regulates nociception and muscle plasticity. Nevertheless, the precise SNS-mediated mechanisms governing hyperalgesia and skeletal muscle atrophy in FM remain unclear. Thus, we employed two distinct FM-like pain models, involving intramuscular injections of acidic saline (pH 4.0) or carrageenan in prepubertal female rats, and evaluated the catecholamine content, adrenergic signaling and overall muscle proteolysis. Subsequently, we assessed the contribution of the SNS to the development of hyperalgesia and muscle atrophy in acidic saline-injected rats treated with clenbuterol (a selective β2-adrenergic receptor agonist) and in animals maintained under baseline conditions and subjected to epinephrine depletion through adrenodemedullation (ADM). Seven days after inducing an FM-like model with acidic saline or carrageenan, we observed widespread mechanical hyperalgesia along with loss of strength and/or muscle mass. These changes were associated with reduced catecholamine content, suggesting a common underlying mechanism. Notably, treatment with a β2-agonist alleviated hyperalgesia and prevented muscle atrophy in acidic saline-induced FM-like pain, while epinephrine depletion induced mechanical hyperalgesia and increased muscle proteolysis in animals under baseline conditions. Together, the results suggest that reduced sympathetic activity is involved in the development of pain and muscle atrophy in the murine model of FM analyzed.</description><subject>Adrenergic beta-Agonists - pharmacology</subject><subject>Animals</subject><subject>Carrageenan - toxicity</subject><subject>Catecholamines - metabolism</subject><subject>Clenbuterol - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Epinephrine</subject><subject>Female</subject><subject>Fibromyalgia</subject><subject>Fibromyalgia - pathology</subject><subject>Fibromyalgia - physiopathology</subject><subject>Hyperalgesia</subject><subject>Hyperalgesia - pathology</subject><subject>Hyperalgesia - physiopathology</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - pathology</subject><subject>Muscle, Skeletal - physiopathology</subject><subject>Muscular Atrophy - pathology</subject><subject>Muscular Atrophy - physiopathology</subject><subject>Pain - pathology</subject><subject>Pain - physiopathology</subject><subject>Proteolysis</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Skeletal muscle</subject><subject>Sympathetic nervous system</subject><subject>Sympathetic Nervous System - drug effects</subject><subject>Sympathetic Nervous System - pathology</subject><subject>Sympathetic Nervous System - physiopathology</subject><issn>0031-9384</issn><issn>1873-507X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE2v1CAUhonReMerP0HD0k1HKFDoypib60dyExOjiTtC4dRhUkoFOqY7f7pMZnQrG5I3z8s5PAi9pGRPCe3eHPfLYcsDHPYtafmeUi6keIR2VEnWCCK_P0Y7Qhhteqb4DXqW85HUwzh7im6Y6vq25jv0-wu41YLDeQuLKQco3mJjiz_5smGfsck5Wm9KRX75csAVwQ5OMMUlwFxwHPFi_IzN7HBYs50Am5JiXQ6fUzxCMDVLpuAQHUznwuiHFMNmph_ePEdPRjNleHG9b9G39_df7z42D58_fLp799BYRllpRkGhd6AG1o_MUcW6DrjqwBEzKCnZYHhvKBOy40S41nRSib6lrFMtd5wDu0WvL-8uKf5cIRcdfLYwTWaGuGbNiCBUtrJTFRUX1KaYc4JRL8kHkzZNiT7L10d9la_P8vVFfu29uo5YhwDuX-uv7Qq8vQBQP3rykHS2Huaq3yewRbvo_zPiD5qWmbI</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>da Silva, Raquel Prado</creator><creator>Costa, Daniely Messias</creator><creator>da Cruz-Filho, João</creator><creator>Santos, Tatiane de Oliveira</creator><creator>dos Anjos-Santos, Hevely Catharine</creator><creator>Vasconcelos, Alan Bruno Silva</creator><creator>Heck, Lilian Carmo</creator><creator>Kettelhut, Ísis do Carmo</creator><creator>Navegantes, Luiz Carlos</creator><creator>dos Santos, José Ronaldo</creator><creator>de Souza, Patrícia Rodrigues Marques</creator><creator>Badauê-Passos Jr, Daniel</creator><creator>Mecawi, André Souza</creator><creator>DeSantana, Josimari Melo</creator><creator>Lustrino, Danilo</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7118-743X</orcidid></search><sort><creationdate>20240701</creationdate><title>Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia</title><author>da Silva, Raquel Prado ; Costa, Daniely Messias ; da Cruz-Filho, João ; Santos, Tatiane de Oliveira ; dos Anjos-Santos, Hevely Catharine ; Vasconcelos, Alan Bruno Silva ; Heck, Lilian Carmo ; Kettelhut, Ísis do Carmo ; Navegantes, Luiz Carlos ; dos Santos, José Ronaldo ; de Souza, Patrícia Rodrigues Marques ; Badauê-Passos Jr, Daniel ; Mecawi, André Souza ; DeSantana, Josimari Melo ; Lustrino, Danilo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c313t-f51e9de8b39f3d18366e486ed0ab8773ba49a13576405d2a678592136824d44e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adrenergic beta-Agonists - pharmacology</topic><topic>Animals</topic><topic>Carrageenan - toxicity</topic><topic>Catecholamines - metabolism</topic><topic>Clenbuterol - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Epinephrine</topic><topic>Female</topic><topic>Fibromyalgia</topic><topic>Fibromyalgia - pathology</topic><topic>Fibromyalgia - physiopathology</topic><topic>Hyperalgesia</topic><topic>Hyperalgesia - pathology</topic><topic>Hyperalgesia - physiopathology</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - pathology</topic><topic>Muscle, Skeletal - physiopathology</topic><topic>Muscular Atrophy - pathology</topic><topic>Muscular Atrophy - physiopathology</topic><topic>Pain - pathology</topic><topic>Pain - physiopathology</topic><topic>Proteolysis</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Skeletal muscle</topic><topic>Sympathetic nervous system</topic><topic>Sympathetic Nervous System - drug effects</topic><topic>Sympathetic Nervous System - pathology</topic><topic>Sympathetic Nervous System - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>da Silva, Raquel Prado</creatorcontrib><creatorcontrib>Costa, Daniely Messias</creatorcontrib><creatorcontrib>da Cruz-Filho, João</creatorcontrib><creatorcontrib>Santos, Tatiane de Oliveira</creatorcontrib><creatorcontrib>dos Anjos-Santos, Hevely Catharine</creatorcontrib><creatorcontrib>Vasconcelos, Alan Bruno Silva</creatorcontrib><creatorcontrib>Heck, Lilian Carmo</creatorcontrib><creatorcontrib>Kettelhut, Ísis do Carmo</creatorcontrib><creatorcontrib>Navegantes, Luiz Carlos</creatorcontrib><creatorcontrib>dos Santos, José Ronaldo</creatorcontrib><creatorcontrib>de Souza, Patrícia Rodrigues Marques</creatorcontrib><creatorcontrib>Badauê-Passos Jr, Daniel</creatorcontrib><creatorcontrib>Mecawi, André Souza</creatorcontrib><creatorcontrib>DeSantana, Josimari Melo</creatorcontrib><creatorcontrib>Lustrino, Danilo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Physiology &amp; behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>da Silva, Raquel Prado</au><au>Costa, Daniely Messias</au><au>da Cruz-Filho, João</au><au>Santos, Tatiane de Oliveira</au><au>dos Anjos-Santos, Hevely Catharine</au><au>Vasconcelos, Alan Bruno Silva</au><au>Heck, Lilian Carmo</au><au>Kettelhut, Ísis do Carmo</au><au>Navegantes, Luiz Carlos</au><au>dos Santos, José Ronaldo</au><au>de Souza, Patrícia Rodrigues Marques</au><au>Badauê-Passos Jr, Daniel</au><au>Mecawi, André Souza</au><au>DeSantana, Josimari Melo</au><au>Lustrino, Danilo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia</atitle><jtitle>Physiology &amp; behavior</jtitle><addtitle>Physiol Behav</addtitle><date>2024-07-01</date><risdate>2024</risdate><volume>281</volume><spage>114575</spage><epage>114575</epage><pages>114575-114575</pages><artnum>114575</artnum><issn>0031-9384</issn><eissn>1873-507X</eissn><abstract>•Plasma epinephrine is decreased in priming models of fibromyalgia-like pain.•Clenbuterol attenuates hyperalgesia in an acid saline-induced fibromyalgia-like pain model.•Clenbuterol mitigates muscle atrophy in fibromyalgia priming model. Fibromyalgia (FM) is characterized by chronic widespread musculoskeletal pain accompanied by fatigue and muscle atrophy. Although its etiology is not known, studies have shown that FM patients exhibit altered function of the sympathetic nervous system (SNS), which regulates nociception and muscle plasticity. Nevertheless, the precise SNS-mediated mechanisms governing hyperalgesia and skeletal muscle atrophy in FM remain unclear. Thus, we employed two distinct FM-like pain models, involving intramuscular injections of acidic saline (pH 4.0) or carrageenan in prepubertal female rats, and evaluated the catecholamine content, adrenergic signaling and overall muscle proteolysis. Subsequently, we assessed the contribution of the SNS to the development of hyperalgesia and muscle atrophy in acidic saline-injected rats treated with clenbuterol (a selective β2-adrenergic receptor agonist) and in animals maintained under baseline conditions and subjected to epinephrine depletion through adrenodemedullation (ADM). Seven days after inducing an FM-like model with acidic saline or carrageenan, we observed widespread mechanical hyperalgesia along with loss of strength and/or muscle mass. These changes were associated with reduced catecholamine content, suggesting a common underlying mechanism. Notably, treatment with a β2-agonist alleviated hyperalgesia and prevented muscle atrophy in acidic saline-induced FM-like pain, while epinephrine depletion induced mechanical hyperalgesia and increased muscle proteolysis in animals under baseline conditions. Together, the results suggest that reduced sympathetic activity is involved in the development of pain and muscle atrophy in the murine model of FM analyzed.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38692384</pmid><doi>10.1016/j.physbeh.2024.114575</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-7118-743X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0031-9384
ispartof Physiology & behavior, 2024-07, Vol.281, p.114575-114575, Article 114575
issn 0031-9384
1873-507X
language eng
recordid cdi_proquest_miscellaneous_3050172768
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adrenergic beta-Agonists - pharmacology
Animals
Carrageenan - toxicity
Catecholamines - metabolism
Clenbuterol - pharmacology
Disease Models, Animal
Epinephrine
Female
Fibromyalgia
Fibromyalgia - pathology
Fibromyalgia - physiopathology
Hyperalgesia
Hyperalgesia - pathology
Hyperalgesia - physiopathology
Muscle, Skeletal - drug effects
Muscle, Skeletal - pathology
Muscle, Skeletal - physiopathology
Muscular Atrophy - pathology
Muscular Atrophy - physiopathology
Pain - pathology
Pain - physiopathology
Proteolysis
Rats
Rats, Sprague-Dawley
Skeletal muscle
Sympathetic nervous system
Sympathetic Nervous System - drug effects
Sympathetic Nervous System - pathology
Sympathetic Nervous System - physiopathology
title Reduced sympathetic activity is associated with the development of pain and muscle atrophy in a female rat model of fibromyalgia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T06%3A39%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20sympathetic%20activity%20is%20associated%20with%20the%20development%20of%20pain%20and%20muscle%20atrophy%20in%20a%20female%20rat%20model%20of%20fibromyalgia&rft.jtitle=Physiology%20&%20behavior&rft.au=da%20Silva,%20Raquel%20Prado&rft.date=2024-07-01&rft.volume=281&rft.spage=114575&rft.epage=114575&rft.pages=114575-114575&rft.artnum=114575&rft.issn=0031-9384&rft.eissn=1873-507X&rft_id=info:doi/10.1016/j.physbeh.2024.114575&rft_dat=%3Cproquest_cross%3E3050172768%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3050172768&rft_id=info:pmid/38692384&rft_els_id=S0031938424001203&rfr_iscdi=true